Paul R. La Monica

Csquare, a data center operator backed by Brookfield, is going public as investors are growing skeptical about AI and IPOs.

Single-stock leveraged ETFs will amplify the daily gains (or losses) of SK Hynix. That’s fine for traders but not longer term investors.

Wolfe Research Chief Investment Strategist Chris Senyek and his team run monthly screens to identify possible targets.

Consumer names are ripe for the pickin’. But it’s risky to buy a stock just because it could be a takeover target. The safest bets are those that will be fine even if they don’t get scooped up.

Healthcare stocks are attractive in a choppy market. These funds, focusing on the broader sector, drugmakers, and biotechs, are worth a look.

Global merger activity reached a record $2.6 trillion in the first half of the year as companies pursued larger acquisitions, while analysts expect dealmaking to broaden into smaller companies.

National Beverage, the maker of LaCroix sparkling water, announced its 13th special dividend in 22 years, sending shares sharply higher despite mixed annual results.

AI spending remains strong and oil prices retreat. What that means for the two hottest sectors over the next six months.

SpaceX’s stock slide may be a reason why the ChatGPT and Claude owners should go public before the IPO window shuts.

Italian media conglomerate Bending Spoons is now trading, following its purchase of AOL earlier this year. The stock looks pricey.

Wall Street sees strong demand for Innio’s gas-powered data center business, but many analysts say the AI power IPO already reflects much of that optimism.

A report that OpenAI could delay its IPO, and stock slides for SpaceX and Cerebras, could slow IPO activity. But a lull may not last long.

Hyperliquid is the hot new crypto, and there’s an ETF to play the trend. Funds focusing on photonics and the HALO trade look promising as well.

SK Hynix will be easier for investors to buy. Will that hurt demand for South Korean funds and the DRAM ETF?

Worries about inflation and Fed rate hikes are hurting gold. It’s no longer a haven. There could be more downside ahead.

Funds that cap losses are growing in popularity. But these buffered, or defined outcome, funds also miss out on big market gains.

The Patient Opportunity Trust takes a value approach to investing. But one of its fund managers says that doesn’t mean it ignores growth.

The Fed may have to hike rates later this year. But investors are focusing more on strong fundamentals for Corporate America and the economy.

The AI chip company’s stock has fallen from its post-IPO highs and is about to report quarterly results. SpaceX investors should take notice.